A securities fraud class action lawsuit has been filed against Applied Therapeutics, Inc. (APLT) by investment.com
RADOR, PENNSYLVANIA – (NewsFile Corp. – January 25, 2025) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) advises investors that a securities lawsuit has been filed in the United States District Court for the Southern District of New York v. Applied Therapies (NASDAQ:), Inc. (“Applied Therapeutics”) (NASDAQ: APLT) on behalf of those who purchased or otherwise acquired Applied Therapeutics securities between January 3, 2024 and December 2, 2024, inclusive (the “Class Period”). The lead prosecutor’s deadline is February 18, 2025.
Contact Kessler Topaz Meltzer & Check, LLP:
If you have suffered losses from applied therapies, you can Click here or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/applied-therapeutics-inc?utm_source=pr&utm_medium=link&utm_campaign=aplt&mktm=r=r
You can also contact a lawyer Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com.
Alleged violation of the defendant:
The complaint alleges that, throughout the class, the defendants made false and/or misleading statements and/or failed to disclose that the applied therapeutics did not adhere to testing protocols and good clinical practice for their drug candidate, which, in turn, created an extremely serious the risk that the trial data will be rejected by the FDA in the context of a new drug application.
Please Click here To watch our video or copy and paste this link into your browser: https://youtu.be/pfwg4tsn1lq
The process of the main prosecutor:
Applied therapy investors can, no later than February 18, 2025, You are seeking to be appointed as lead class representative plaintiff through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. The lead plaintiff is the representative party acting on behalf of all class members in directing the litigation. The lead plaintiff is usually an investor or a small group of investors who have the greatest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the classes, and those attorneys, if approved by the Court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision to serve as lead plaintiff or not.
Kessler Topaz Meltzer & Check, LLP encourages applied therapeutics investors who have suffered significant losses to contact the company directly for more information.
Click here To apply for a case or go to: https://www.ktmc.com/new-cases/applied-therapeutics-inc?utm_source=pr&utm_medium=link&utm_campaign=aplt&mktm=r=r
About Kessler Topaz Meltzer & Check, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts nationwide and around the world. The company has developed a global reputation for excellence and has won billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by companies and fiduciaries. No objection was filed in this action by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Chec, LLP, visit www.ktmc.com.
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future results.
To view the original version of this release, visit https://www.newsfilecorp.com/release/238414
